Nuclivision
Ghent
About Nuclivision
Nuclivision provides novel radiotracers and treatments for oncology that develop AI-driven solutions to help patients by improving the quality, safety, and accessibility of nuclear medicine.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $5.7M
- Funding stage: Seed
- Last round: Seed (Apr 2025)
- Website: nuclivision.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Medical Device, Oncology
Social Profiles
Canonical: https://fsome.com/organization/nuclivision-74943 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.